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Abstract
Children with SCT have an increased risk of suboptimal neurodevelopment. Previous stud-
ies have shown an elevated risk for neurobehavioral problems in individuals with SCT.
However, not much is known about neurobehavioral problems in very young children;
knowledge that could help with early identification of children at risk for suboptimal devel-
opment, and that could help establish targets for early intervention. This study addressed
the question of what the behavioral profile of children with SCT aged 1–5 years
looks like. In total, 182 children aged 1–5 years participated in this study (NSCT=87,
Nnonclinical controls = 95). Recruitment and assessment took place in the Netherlands and the
United States. The SCT groupwas recruited through prospective follow-up (50%), informa-
tion seeking parents (31%), and clinical referral (18%). Behavioral profiles were assessed
with the child behavior checklist and the ages-and-stages social–emotional questionnaire.
Levels of parent-rated problem behavior were higher in children with SCT. Difficul-
ties with overall social–emotional functioning were already present in 1-year-olds,
and elevated scores were persistent across the full age range. Affective and pervasive
developmental behaviors were seen in late toddlerhood and prominent at preschool
age. Anxiety, attention deficit, and oppositional defiant behaviors were seen in pre-
school-aged children. Within this cross-sectional study, the developmental trajectory
of affective, pervasive developmental, and oppositional defiant behaviors seemed to
be different for SCT children than nonclinical controls.
Collectively, these results demonstrate the importance of behavioral screening for
behavioral problems in routine clinical care for children with SCT from a young age.
Social–emotional problems may require special attention, as these problems seem most
prominent, showing increased risk across the full age range, and with these problems
occurring regardless of the timing of diagnosis, and across all three SCT karyotypes.
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1 | INTRODUCTION
Sex chromosome trisomy (SCT; the presence of an extra X or Y chro-
mosome) is one of the most common chromosomal duplications in
humans, with an estimated prevalence from 1–650 to 1–1,000 live
births (Bojesen, Juul, & Gravholt, 2003; Groth, Skakkebaek, Høst,
Gravholt, & Bojesen, 2013; Morris, Alberman, Scott, & Jacobs, 2008).
Children with SCT have an increased risk of suboptimal neuro-
development, including problems with language development, social
cognition, and executive functioning (for a review see Urbanus, van
Rijn, & Swaab, 2020). An increased risk for neurodevelopmental disor-
ders, such as autism spectrum disorder (ASD), and attention deficit
hyperactivity disorder (ADHD) has been described in all subtypes of
SCT (for a review see van Rijn, 2019). Although there is overlap in
developmental phenotypes, some behavioral and emotional difficul-
ties are found to be more common for specific karyotypes. Examples
include high levels of anxiety in girls and boys with an extra X chromo-
some (Tartaglia, Howell, Sutherland, Wilson, & Wilson, 2010; Verri,
Cremante, Clerici, Destefani, & Radicioni, 2010), and high levels of
impulsivity and externalizing behavior in boys with an extra Y chromo-
some (Hong & Reiss, 2014).
Most studies on the impact of SCT on neurodevelopment have
been conducted in school-aged children, adolescents, and adults, and
have shown that individuals with SCT have an elevated risk for serious
behavioral dysfunctions. It is likely that early signs of these behavioral
challenges emerge when children are younger. However, we have very
little knowledge about the behavioral profile of young children with
SCT and the impact of SCT on the neurodevelopment of toddlers and
preschoolers. For that reason, this study aimed to describe the behav-
ioral profile of children with SCT in a very early developmental stage.
It should be noted that while studies generally indicate increased
risk for behavioral problems in SCT, it has also been indicated that the
behavioral profile of individuals with SCT is highly variable (e.g., Ross
et al., 2012; Samango-Sprouse, Stapleton, Sadeghin, &
Gropman, 2013; Tartaglia, Cordeiro, Howell, Wilson, & Janusz, 2010).
Although SCT is associated with risk for behavioral problems and psy-
chopathology, some individuals function without any problems. It is
unknown which mechanisms modulate this variability. However, the
developing brain could give more insight on when psychopathology
emerges and how it unfolds (Andersen, 2003), and possibly the matu-
ration of the brain could help explain the observed variability of out-
comes in individuals with SCT.
It is also important to gain more knowledge about the behavioral pro-
file, and possible early presentation of behavioral problems in young chil-
dren with SCT, to allow for development of age-specific screening (e.g., to
identify children who are at risk for more serious neurodevelopmental dis-
orders as early in life as possible), and for development of treatment rec-
ommendations (i.e., identifying targets for intervention and preventive
support). Knowledge about the early behavioral profile of children with
SCT can help reduce the risk of behavioral dysfunction later in life for chil-
dren who are at risk for developing psychopathology.
Taken together, this study aimed to describe the social–emo-
tional and behavioral profile of children aged 1 to 5 years with SCT.
Since these early stages of childhood are characterized by substan-
tial developmental changes in the brain, we expect high variability
within this age group. For that reason, we will not merely focus on
mean group findings, but also aim to describe the variability within
this age group with risk assessment (i.e., how many of the children
scored within borderline or clinical ranges). Our focus will be on age-
related presentation of the behavioral phenotype, to evaluate if the
developmental impact can be found within this window of 1–
5 years. Moreover, we were also interested to see if there is the sta-
bility of symptoms over time within this age range. Secondary to
these research questions, differences in behavior problems between
children with SCT and nonclinical controls were compared by karyo-
types (XXX vs. XX, XXY vs. XY, XYY vs. XY). In addition, since prob-
lem behavior might be associated with the reason for the detection
of the SCT, behavioral outcomes were compared between pre- and




The present study is part of a larger ongoing project (the TRIXY Early
Childhood Study - Leiden the Netherlands), which includes children
with SCT and nonclinical controls aged 1–7 years. The TRIXY Early
Childhood Study is a longitudinal study that aims to identify neu-
rodevelopmental risk in young children with an extra X or Y chromo-
some. For this study, only children aged 1 up to and including 5 years
were included.
In total, 182 children participated in this study, 87 children with
SCT and 95 nonclinical age-matched children from the typical popula-
tion. Ages ranged from 11 months to 5 years and 11 months (see
Table 1 for mean ages per karyotype). Of the 87 children with SCT,
60 children received a prenatal diagnosis (i.e., because of [routine]
prenatal screening or advanced maternal age). Of the 27 children who
received a postnatal diagnosis, 13 received the diagnosis because of a
developmental delay, 12 because of physical and/or growth problems,
and 2 because of medical concerns.
Recruitment and assessment took place on two sites: The Tri-
somy of the X and Y chromosomes (TRIXY) Expert Center the
Netherlands, and the eXtraordinarY Kids Clinic in Developmental
Pediatrics at Children's Hospital Colorado in the USA. Children in
the SCT group were recruited with the help of clinical genetics
departments (from the Netherlands, Colorado, and Belgium), pedi-
atricians, and national advocacy or support groups for individuals
with SCT with recruitment flyers and postings on the internet (e.g.,
TRIXY website and the eXtraordinarY Kids Facebook page). For
the SCT group, ascertainment bias was assessed and three sub-
groups were identified: (a) “Active prospective follow-up,” which
included families who were actively followed after prenatal diag-
nosis (50% of the SCT group), (b) “Information seeking parents,”
which included families who were actively looking for more
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information about SCT without having specific concerns about the
behavior of their child (31% of the SCT group), and (c) “Clinically
referred cases,” which included families seeking professional help
based on specific concerns about their child's development (18%
of the SCT group). Nonclinical controls were recruited from the
western part of the Netherlands. Schools and daycare centers
received information brochures that were distributed to parents
with children of eligible age. Parents who were interested in par-
ticipating contacted the researchers.
For all participants, inclusion criteria were Dutch or English-
speaking (child and parent). For the SCT group, SCT was defined by
trisomy in at least 80% of the cells, which was confirmed in the study
by standard karyotyping. Exclusion criteria for all participants included
a history of traumatic brain injury, neurological illness, severely
impaired hearing or sight, or colorblindness. For ethical reasons, chil-
dren in the control group were not subjected to genetic screening, as
these children were meant to be a representation of the general popu-
lation. As the prevalence of SCT is ~1 in 1000, the risk of having one
or more children with SCT in the control group was considered mini-
mal and acceptable.
For all children, background information such as the presence of a
second caregiver and marital status and age of the primary caregiver
was assessed. Overall, 95.6% of the parents indicated that their child
has a second caregiver, with no significant differences between the
SCT and the nonclinical control group χ2 (1, N = 182) = .36, p = .55.
Regarding the marital status of the primary caregiver, 92.9% indicated
that they were (re)married, registered partners, or living with their
partner. Of the remaining parents, 4.4% indicated that they were sin-
gle and never married, 2.2% indicated that they were single and
divorced, and 0.5% indicated that they were widowed. The distribu-
tion of marital status was similar for children in the SCT and children
in the nonclinical control group χ2 (3, N = 182) = 2.37, p = .50. Finally,
the age of the primary caregiver (93% female) ranged from 23 to
50 years. There was a significant difference between the research
groups (p < .001); on average, the primary caregivers of the children in
the SCT group were older (M = 38.51, SD = 4.71) than the primary
caregivers of the children in the nonclinical control group (M = 35.06,
SD = 5.18).
2.2 | Instruments
2.2.1 | Overall social–emotional functioning
Parents completed the age-appropriate version of the ages-and-
stages social–emotional questionnaire (ASQ-SE-2; Squires, Bricker, &
Twombly, 2015). The ASQ-SE-2 is a parent-report screening measure
of social and emotional development, and can be used to assess chil-
dren aged 1 to 72 months. Different forms are used, depending on
the age of the child, with the number of questions ranging from 19 to
33. The items on the ASQ-SE-2 address seven behavioral constructs:
(a) Self-regulation, (b) compliance, (c) adaptive functioning, (d) auton-
omy, (e) affect, (f) social-communication, and (g) interaction. Parents
can respond to each item with “rarely or never", “sometimes”, or “most
of the time”. In addition, parents can indicate if the behavior is a con-
cern for each item. Answers on the seven constructs add up to a total
score, with higher scores indicating increased risk for social–emotional
deficits or delays.
2.2.2 | Behavioral functioning
Parents were asked to complete the child behavior checklist (CBCL;
Achenbach & Ruffle, 2000) for children aged 1–5 years. The CBCL is
a standardized measure of behavioral problems and is used to assess
competencies and psychopathology. The CBCL contains 100 items,
which assess emotional and behavioral problems that occurred in
the past 6 months. Parents can answer each item with one of the fol-
lowing answers: (0) not true, (1) somewhat or sometimes true, (2)
very true or often true, with higher scores indicating more problems.
Answers on the items yield empirical syndrome scales and DSM-ori-
ented scales. For this study, the DSM-Oriented scales were used to
assess behavioral functioning, since these are based on profiles more
than on individual behavioral items. The DSM-oriented scales consist
of five different profiles: (a) Affective problems (as an indication for
mood disorders), (b) anxiety problems, (c) pervasive developmental
problems (as an indication of disorders on the autism spectrum), (d)
attention-deficit/hyperactivity problems, and (e) oppositional defiant
problems. These five scales overlap with the Diagnostic and Statisti-
cal Manual of Mental Disorders (American Psychiatric
Association, 2000)
2.3 | Procedure
This study was approved by the Ethical Committee of Leiden Univer-
sity Medical Center, the Netherlands, and the Colorado Multiple Insti-
tutional Review Board (COMIRB) in Colorado, USA. After describing
the study to the parent(s) of the child, written informed consent
according to the declaration of Helsinki was obtained. The primary
caregiving parent (93% mother) of the child completed both question-
naires, either in Dutch or in English.
TABLE 1 Mean ages per karyotype
XXY XXX XYY XY XX
N 40 28 19 40 55
Mean age in months (SD) 33.48 (17.05) 45.89 (18.74) 37.47 (19.87) 42.28 (18.32) 42.38 (18.86)
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The assessment took place at different sites (Colorado USA, the
Netherlands, Belgium). Researchers from Leiden University were
responsible for project and data-management (i.e., training and super-
vision of researchers, processing, and scoring of data).
2.4 | Statistical analyses
2.4.1 | Raw scores versus standardized scores
For both measurements, two types of scores were used. First, raw
scores were used to compare the children with SCT and the non-
clinical controls. As the ASQ-SE-2 has different items depending on
age, ASQ raw scores were corrected for the maximum possible score
(which depended on the form used). Secondly, normed or cutoff
scores were used for risk assessment. For the CBCL standardized T-
scores (M = 50, SD = 10) were used, where T < 65 was classified as
“nonclinical”, 65 < T < 70 as “borderline”, and T > 70 as “clinical”. For
the ASQ-SE-2, cutoff scores were used (depending on the form used)
where children were categorized as “below risk/below cutoff”, “bor-
derline/monitoring area”, or “at risk/above cutoff”.
2.4.2 | Age groups
Participants were divided into age groups; resulting in three groups (a)
aged 11–23 months (labeled as the 1-year-old group or early toddler-
hood; NSCT = 31, Ncontrols = 29), (b) 24–47 months (labeled as the 2–3-
year-old group, or late toddlerhood; NSCT = 27, Ncontrols = 23), and (c)
48–71months (labeled as the 4–5-year-old group, or preschool-age;
NSCT = 29, Ncontrols = 43). With a one-way analysis of variance
(ANOVA), we tested if there were differences between SCT and non-
clinical control group within each age group. There were no statisti-
cally significant differences, F(1,180) = 1.83, p = .178.
2.4.3 | Analyses
Data were analyzed using the Statistical Package for the Social Sci-
ences (SPSS) Version 25. Level of significance was set at p ≤ .05, two-
tailed. Multivariate analysis of variance (MANOVA) was used to test
for differences, with the ASQ-SE-2 and the CBCL-DSM Scales (affec-
tive, anxiety, pervasive developmental, attention deficit, oppositional
defiant) as dependent variables and research group and age groups as
independent variables. When unequal variance–covariance was indi-
cated (i.e., Box's M test p < .05), Pillai's trace was used to assess the
multivariate effect. Significant multivariate effects were then further
analyzed with univariate ANOVAs and simple effect analyses to deter-
mine the locus of the statistically significant multivariate effect. Risk
assessment was done with cross-tabulation analysis. Post hoc ana-
lyses were used to identify significant group effects. Effect sizes were
calculated with Cohen's d when applicable.
3 | RESULTS
First, we addressed the question what the behavioral profile of chil-
dren ages 1–5 with SCT looks like. As different behaviors are
expected at different ages, the focus is on differences within age
groups (SCT vs. nonclinical controls) and between age groups within
the SCT group (to assess developmental stability). Lastly, the behav-
ioral profile of boys (with vs. without SCT) and of girls (with vs. with-
out SCT) aged 1–5 years was compared, and the effect of time of
diagnosis and ascertainment was assessed.
3.1 | Social–emotional functioning and behavioral
difficulties: SCT versus nonclinical controls
There was a significant effect of research group on behavioral pheno-
type (social–emotional functioning and behavioral difficulties), Pillai's
trace = .262, F(6,175) = 10.37, p < .001, partial ƞ2 = .262.
Univariate ANOVAs for the social–emotional scale and the five
DSM scales indicated that on average, children with SCT showed
more problems in overall social–emotional functioning, and more
behavioral symptoms of affective and pervasive developmental
problems compared with the nonclinical control group. Cohen's d
effect sizes (see Table 2) indicate moderate to high clinical signifi-
cance. For the anxiety, attention deficit, and oppositional defiant
scales, there was no significant difference in the behavioral
symptoms.
In addition to average outcomes, we were also interested how
many of the children in each group scored around or above clinical cut-
off. The cross-tabulation analysis was used for risk assessment; that is,
how many of the children in each group scored in the nonclinical, bor-
derline, and clinical range. As the CBCL provides normed scores for
children aged 18 months and above, children younger than 18 months
were excluded from the cross-tabulation analyses with CBCL DSM
scores.
All children were included in the analysis with ASQ social–emo-
tional scores. The numbers were divided by the total number of par-
ticipants in each group and shown in Table 3 as percentages per
group. Pearson Chi-square indicates significant group differences for
overall social–emotional functioning, and affective problems, anxiety
problems, and pervasive developmental problems, indicating differ-
ences in distribution between groups (see Figure 1 for a visual
representation).
3.2 | Social–emotional functioning and behavioral
difficulties across ages
Within each age group, differences in the behavioral outcomes
between the SCT and nonclinical control group were analyzed with
three separate MANOVAs. Descriptive statistics for all MANOVAs
can be found in Table 4.
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3.2.1 | 1-year-old children: Early toddlerhood
There was a significant effect of research group on behavioral pheno-
type (social–emotional functioning and behavioral difficulties), Pillai's
trace = .292, F(6,53) = 3.64, p = .004, partial ƞ2 = .292. Univariate
ANOVAs for the social–emotional scale and the five DSM scales indi-
cated significant differences for oppositional defiant behavior and
overall social–emotional functioning. On average, children with SCT
showed more problems in overall social–emotional functioning than
nonclinical controls (see Table 4 for descriptives, and Figure 2). Con-
versely, for oppositional defiant behavior, children with SCT on aver-
age showed fewer problems than nonclinical controls. No significant
group differences were found for affective problems, anxiety prob-
lems, pervasive developmental problems, and attention deficit prob-
lems, indicating that in 1-year-olds, children with SCT showed similar
amounts of these behaviors to nonclinical controls.
3.2.2 | 2–3-Year-old children: Late toddlerhood
There was a significant effect of the research group on behavioral
phenotype (social–emotional functioning and behavioral difficul-
ties), Pillai's trace = .369, F(6,43) = 4.19, p = .002, partial ƞ2 = .369.
Univariate ANOVAs for the social–emotional scale and the five
DSM scales indicated significant differences for overall social–
emotional functioning, and affective and pervasive developmental
problems. On average, children with SCT showed more problems
in overall social–emotional functioning, and more behavioral symp-
toms of affective problems and pervasive developmental problems
than nonclinical controls (see Table 4 for descriptives, and Fig-
ure 2). No significant group differences were found for anxiety
problems, attention deficit problems, or oppositional defiant prob-
lems, indicating that in 2–3-year-olds, children with SCT group
showed similar amounts of these behaviors to nonclinical controls.
TABLE 2 Behavioral differences SCT versus control groups
SCT N = 87 Nonclinical controls N = 95 p-value Cohen's d
ASQ-SE-2a Mean (SD) Mean (SD)
Social–emotional functioning 11.48 (10.14) 5.37 (3.79) < .001 .80
CBCL DSM scalesa
Affective 2.72 (2.13) 1.49 (1.49) < .001 .67
Anxiety 3.33 (3.32) 2.52 (2.30) .053 .28
Pervasive developmental 5.05 (4.23) 2.79 (2.23) < .001 .67
Attention deficit 4.57 (2.72) 4.05 (2.50) .179 .20
Oppositional defiant 3.53 (3.08) 3.59 (2.43) .882 .02
aHigher scores denote more problems.





ASQ-SE-2a Below risk Monitoring area At risk
Social–emotional
functioning
SCT 59.8% 18.4% 21.8% <.001
Control 95.8% 2.1% 2.1%
CBCL DSM Scalesa Nonclinical range
T < 65
Borderline range
65 < T < 70
Clinical range
T > 70
Affective SCT 88.4% 4.3% 7.2% .018
Control 98.8% 1.2% 0%
Anxiety SCT 84.1% 1.4% 14.5% .019
Control 95.3% 2.4% 2.4%
Pervasive developmental SCT 62.3% 14.5% 23.2% <.001
Control 94.1% 3.5% 2.4%
Attention deficit SCT 95.7% 0% 4.3% .316
Control 97.6% 1.2% 1.2%
Oppositional defiant SCT 85.5% 7.2% 7.2% .189
Control 94.1% 2.4% 3.5%
aHigher scores denote more problems.
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3.2.3 | 4–5-year-old children: Preschool-age
There was a significant effect of the research group on behavioral
phenotype (social–emotional functioning and behavioral difficulties),
Pillai's trace = .346, F(6,65) = 5.72, p < .001, partial ƞ2 = .346.
Univariate ANOVAs for the social–emotional scale and the five
DSM scales indicated significant differences for all scales (see Table 4
for descriptives, and Figure 2). On average, children with SCT
showed more problems in overall social–emotional functioning and
more, behavioral symptoms of affective problems, anxiety problems,
and pervasive developmental problems. In addition, children with
SCT also showed more behavioral symptoms of attention-deficit
problems and oppositional defiant problems than nonclinical
controls.
3.2.4 | Developmental stability
To assess whether there is developmental stability or variability of
problem behavior, a MANOVA was used to test for significant differ-
ences, with the social–emotional scale and the DSM Scales (affective,
anxiety, pervasive developmental, attention deficit, oppositional defi-
ant) as dependent variables and research group and age groups as
independent variables. Only the outcomes of the research group ×
age group interaction will be reported.
There was no significant research group × age group interaction
effect on behavioral phenotype (social–emotional functioning and
behavioral difficulties), Pillai's trace = .111, F(12,344) = 1.69, p = .068,
partial ƞ2 = .056. Univariate effects, however, showed significant
research group × age group interactions for affective problems (F
[2,176] = 3.04, p = .050, partial ƞ2 = .033), pervasive developmental
problems (F[2,176] = 7.57, p = .001, partial ƞ2 = .079), and opposi-
tional defiant problems (F[2,176] = 6.38, p = .002, partial ƞ2 = .068).
Significant effects were further analyzed with simple effect analyses,
relevant means can be found in Table 4.
3.2.5 | Affective problems
The statistically significant effect was produced by the 2–3-year-old,
and the 4–5-year-old SCT children, who showed significantly more
affective problems than the 2–3-year-old, and 4–5-year-old non-
clinical controls. Conversely, in the 1-year-old group, both the SCT
children and the nonclinical controls showed similar amounts of affec-
tive problems. These results collectively indicate that it is possible
that—in this cross-sectional sample—the developmental trajectory is
different for SCT children and nonclinical controls (see Figure 2).
3.2.6 | Pervasive developmental problems
The statistically significant effect was produced by the 2–3-year-old,
and the 4–5-year-old SCT children, who showed significantly more
pervasive developmental problems than the 2–3-year-old, and 4–5-
year-old nonclinical controls. Conversely, in the 1-year-old group,
both the SCT children and the nonclinical controls showed similar
amounts of pervasive developmental problems. These results collec-
tively indicate that possibly—in this cross-sectional sample—the devel-
opmental trajectory is different for SCT children and nonclinical
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* * * *
F IGURE 1 Proportion of children with SCT with ASQ-SE and CBCL DSM cutoff score in the below risk/nonclinical, monitoring/borderline,
and at risk/clinical ranges. *Distribution significantly different when compared to nonclinical controls (p < .05); Nsct DSM scales = 69, Nsct
ASQ-SE = 87
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3.2.7 | Oppositional defiant problems
The statistically significant effect was produced by the 4–5-year-old
SCT children, who showed significantly more oppositional defiant
problems than the nonclinical controls. Conversely, in the 1-year-olds,
the children with SCT showed significantly fewer oppositional defiant
problems than nonclinical controls. Finally, in the 2–3-year-old group,
both the SCT children and the nonclinical controls showed similar
amounts of oppositional defiant problems. These results collectively
indicate that it is possible that—in this cross-sectional sample—the
developmental trajectory is different for SCT children and nonclinical
controls (see Figure 2).
3.3 | Social–emotional and behavioral differences
between groups: Gender/karyotype differences, time
of diagnosis, and ascertainment
As we were also interested in the specific behavioral profile of boys
and girls, and the individual karyotype group, we compared boys and
girls separately (i.e., girls with/without +1X, boys with/without +1X,
and boys with/without +1Y). In addition, the effect time of diagnosis
and the reason for enrollment (i.e., ascertainment) were assessed sep-
arately. It should be noted that the factor age was left out of these
analyses; results are shown as averages across the whole age range
(1–6 years).
3.3.1 | Social–emotional and behavioral
differences between gender/karyotype
Three one-way between-subjects MANOVA were conducted on six
dependent variables (CBCL-DSM scales; affective, anxiety, pervasive
developmental, attention deficit, oppositional defiant, and the ASQ
social–emotional scale). The independent variables were Karyotype
(XXX, XX), (XXY, XY), and (XYY, XY).
There was a significant effect of karyotypes on behavioral pheno-
type (social–emotional functioning and behavioral difficulties) (XXX
Pillai's trace = .345, F(6,76) = 6.67, p < .001, partial ƞ2 = .345; XXY
Pillai's trace = .320, F(6,73) = 5.72, p < .001, partial ƞ2 = .320; XYY
Pillai's trace = .351, F(6,52) = 4.69, p = .001, partial ƞ2 = .351). Univari-
ate ANOVAs for the social–emotional scale and the five DSM scales
were conducted on each dependent measure separately for each kar-
yotype to determine the locus of the statistically significant multivari-
ate effect. Results are shown in Table 5.
3.3.2 | Time of diagnosis: Prenatal versus postnatal
diagnosis
A one-way between-subjects MANOVA was conducted on six depen-
dent variables (CBCL-DSM scales; affective, anxiety, pervasive devel-
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emotional scale). The independent variable was the time of diagnosis
(prenatal, postnatal, controls).
There was a significant effect of time of diagnosis on behavioral
phenotype (social–emotional functioning and behavioral difficulties),
Pillai's trace = .460, F(12,350) = 8.70, p < .001, partial ƞ2 = .230.
Univariate ANOVAs for the social–emotional scale and the five
DSM scales indicated significant differences for all scales except for
attention deficit problems, which was not significant. Post-hoc ana-
lyses were used to determine which group differences were signifi-
cantly different (see Table 6). For overall social–emotional
functioning, children with SCT, regardless of the time of diagnosis,
showed more problems than controls. For affective problems, perva-
sive developmental problems, and oppositional defiant problems, chil-
dren who were diagnosed postnatally showed significantly more of
these behavioral problems than children with prenatal diagnosis and
controls, with the latter not significantly differing. For anxiety prob-
lems, although there was a significant group effect, post hoc analysis
failed to reach significance.
3.3.3 | Ascertainment bias
Within the SCT group, we tested for differences on the behavioral
outcomes between the three ascertainment groups with MANOVA.
There were no significant differences for the behavioral outcomes
(see Table 7); how children enrolled in the study did not appear to
affect the data on behavioral outcomes.
4 | DISCUSSION
This study aimed to describe the early behavioral profile of toddlers
and preschoolers with SCT, and more specifically to identify if the pre-
sentation of the behavioral phenotype is age-dependent in a large
group of children with SCT aged 1–5 years. First, we addressed the
question whether behavioral problems could already be found in very
young children; between the ages of 1–5 years. Results indicated that
children with SCT showed more problems with overall social–emo-
tional functioning, and more behavioral symptoms of affective and
pervasive developmental problems than children without SCT. Effect
sizes indicated moderate to high clinical significance, indicating that
these behaviors are important to monitor during development. When
we look at risk assessment, much variability within the SCT group was
found, with some children showing no (behavioral) problems, and
other children showing (behavioral) problems at a clinical level. Over-
all, the majority of children with SCT scored within the nonclinical
range on the CBCL and ASQ-SE-2 (Table 3). However, there were sig-
nificantly more children in the SCT group than the control group in
the borderline or clinical range for overall social–emotional function-
ing, and for affective, anxiety, and pervasive developmental behavioral
problems, with overall social–emotional functioning and pervasive
developmental behaviors seeming to be affected the most. These
findings are in concordance with results of similar studies evaluating
categorical results of behavioral findings such as Ross et al. (2012),
and Tartaglia, Cordeiro, et al. (2010). In sum, these results show that
in some children with SCT differences in overall social–emotional
functioning can be identified even at a very young age (as early as in
1-year-old children) and that when problems are present they are
highest in the domains of affective and pervasive developmental
behaviors.
Key to our research question, we further explored the question
whether differences in behavioral problems between children with
and without SCT were age-dependent. Already in 1-year olds, there
were significant differences between the SCT and control group in
overall social–emotional functioning; children with SCT showed more
difficulties with overall social–emotional functioning than the non-
clinical controls. Oppositional defiant problems, however, were less
frequent in the SCT group compared to the control group. In the 2–3-
year-old group, the children with SCT also showed more problems in
































F IGURE 2 Mean scores for affective problems, pervasive developmental problems, and oppositional defiant problems at different ages: SCT
versus nonclinical controls
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pervasive developmental problems. Finally, in the 4–5 year-olds, the
children with SCT showed more problems across all domains. Taken
together, these results show that already in toddlerhood, children with
SCT are at risk for suboptimal behavioral development, and this risk
increases and expands across behavioral domains as children get
older. From a developmental perspective, it is possible that a subset
of challenging behaviors will not emerge until later in development,
depending on brain maturation. For example, in our study, only the 4–
5 year-olds with SCT showed increased levels of ADHD symptoms,
which fits with ADHD typically being diagnosed later in development
(i.e., around 7–9 years; Kessler et al., 2007), when attentional expecta-
tions increase. These findings deserve additional study with a longitu-
dinal study design, and with consideration of other factors that may
contribute to behavioral differences, such as cognitive or language
skills.
In addition, we addressed the question whether there was devel-
opmental stability or variability of problem behavior; that is, is the
developmental path—within this cross-sectional sample—the same in
the SCT group as it is in the control group. Results indicated that there
was developmental variability for affective behavior, pervasive devel-
opmental behavior, and oppositional defiant behavior. Although chil-
dren with SCT did not differ from nonclinical controls (or in the case
of oppositional defiant behavior, showed even fewer problems) in
early toddlerhood, children with SCT showed more problem behaviors
in late toddlerhood and preschool age. While this is a cross-sectional
sample, these findings suggest that the developmental path may be
different for controls and children with SCT, and that the impact of
behavior problems between children with and without SCT increases
as children get older. It should also be noted that for example overall
social–emotional functioning did not show this developmental vari-
ability, but a more stable development, which fits with our other find-
ings that children with SCT scored differently than controls on all
ages; problems with overall social–emotional functioning are persis-
tent over time.
When exploring differences of each karyotype compared with
sex-matched controls, results showed that social–emotional and
affective domains were higher for all SCTkaryotypes. However, anxi-
ety symptoms were more significant only in the XXX group, and per-
vasive developmental problems only in XXX and XYY. This pattern is
interesting and consistent with previous studies evaluating ASD
symptoms in older male children with SCT, where males with XYY
have been shown to have a higher risk for pervasive developmental
and autism symptoms compared to XXY (Cordeiro, Tartaglia, Roeltgen,
& Ross, 2012; Ross et al., 2012; Tartaglia et al., 2017). Further, anxiety
symptoms and anxiety disorders are recognized as risks in XXX in later
childhood and adulthood (Freilinger et al., 2018; van Rijn &
Swaab, 2015; Wigby et al., 2016), and these findings suggest symp-
toms of anxiety may be detected in some very young girls with XXX,
which gives promise for early detection and intervention opportuni-
ties. Pervasive developmental and autism symptoms have also been
identified in other older cohorts with XXX (Bishop et al., 2011; van
Rijn et al., 2014), and further study of the prevalence and profile of
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When we look at the time of diagnosis, it appears that even chil-
dren with a prenatal diagnosis on average display more difficulties
with overall social–emotional functioning than controls; indicating
that difficulties with social–emotional functioning can be very persis-
tent. In addition, children with a postnatal diagnosis, often show more
behavior problems compared with both controls and prenatally diag-
nosed children with SCT. This has been shown consistently in other
studies (Bardsley et al., 2013; Bishop et al., 2011; Samango-Sprouse
et al., 2018), and is very important in counseling families with a prena-
tal diagnosis. This finding is not surprising, as a postnatal diagnosis is
often made because of behavioral and/or physical problems. In addi-
tion, it is possible that parents who receive the diagnosis before birth
are more aware of the possibilities of (behavioral) outcomes, and for
that reason possibly already participate in interventions and preven-
tive support, such as psycho-education or behavioral interventions at
a young age. These outcomes stress the need for early identification
and monitoring, and for more comprehensive evaluation of the longi-
tudinal behavioral profiles in a prenatally identified cohort.
Lastly, we looked at ascertainment bias, and found no significant
differences between the prospective follow-up group, information
seeking parents group, or clinically referred cases group. It is impor-
tant to note however, that bias within the research sample will always
be present. Although it is expected that more individuals will be
diagnosed with the introduction of less invasive methods during preg-
nancy (Samango-Sprouse, Keen, Sadeghin, & Gropman, 2017), two
decades ago, only around 25% of individuals with SCT was diagnosed
(Abramsky & Chapple, 1997). As noninvasive prenatal screening is not
part of routine screening in all countries, the percentage of individuals
who will be diagnosed is variable, and results of the research will not
be generalizable to all individuals with SCT. However, it is possible to
generalize our results to children who are diagnosed with SCT.
This study has both strengths and limitations. One of the limita-
tions of this study is its design, with a cross-sectional rather than a
longitudinal perspective. It is important that future studies will follow
children over time, to monitor the behavioral pattern across ages. It
should be noted, however, that (to our knowledge) this is one of the
first studies to research the behavioral profile of very young children
with SCT. In addition, with our relatively large sample size, we were
able to look for behavioral differences at specific ages (i.e., early tod-
dlerhood, late toddlerhood, preschool age); our results highlight the
importance of early identification of children at risk, and show that
already when a child is 1-year-old problem behaviors, especially with
overall social–emotional functioning, can occur. Future research could
focus on neurocognitive and environmental factors (e.g., SES and ser-
vices received) that could serve as risk- or protective factors in the
development of behavior, as there is a complex relation between
TABLE 6 Differences in behavioral problems: Time of diagnosis
Prenatal N = 60 Postnatal N = 27 Controls N = 95 p-value Post hoc
ASQ-SE-2a Mean (SD) Mean (SD) Mean (SD)
Social–emotional functioning 9.83 (6.20) 15.13 (15.26) 5.37 (3.79) <.001 C < pre = post
CBCL DSM scalesa
Affective 2.12 (1.72) 4.07 (2.69) 1.49 (1.49) < .001 C = pre < post
Anxiety 2.78 (2.69) 4.56 (4.21) 2.52 (2.30) .004 n.s.
Pervasive developmental 3.78 (3.30) 7.85 (4.75) 2.79 (2.23) < .001 C = pre < post
Attention deficit 4.33 (2.69) 5.11 (2.75) 4.05 (2.50) n.s. n/a
Oppositional defiant 2.78 (2.62) 5.11 (3.42) 3.59 (2.43) .001 C = pre < post
Abbreviations: c, nonclinical controls; n.s., not significant; pre, prenatal diagnosis of SCT; post, postnatal diagnosis of SCT.
aHigher scores denote more problems.
TABLE 7 Differences in behavioral profiles across ascertainment groups
Prospective follow-up N = 44 Information seeking parents N = 27 Clinically referred cases N = 16 p-value
ASQ-SE-2a Mean (SD) Mean (SD) Mean (SD)
Social–emotional functioning 10.70 (10.96) 11.60 (10.38) 13.40 (7.28) .682
CBCL DSM scalesa
Affective 2.36 (2.18) 2.74 (1.87) 3.69 (2.21) .137
Anxiety 2.98 (2.81) 3.81 (4.04) 3.50 (3.39) .571
Pervasive developmental 4.18 (4.33) 5.78 (4.15) 6.19 (3.78) .173
Attention deficit 4.61 (2.70) 4.30 (3.06) 4.94 (2.24) .726
Oppositional defiant 3.39 (3.32) 3.26 (3.11) 4.38 (2.25) .507
aHigher scores denote more problems.
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genetics, environmental factors and neuro(behavioral) development
(Karmiloff-Smith, 2009).
Social–emotional and behavioral problems have been negatively
associated with a child's daily functioning. Social competence, school
performance, and peer acceptance, for example, can be affected
because a child experiences behavioral problems (de Lijster et
al., 2019). The presence of behavioral problems during early childhood
could be predictive of later psychopathology and severity of behav-
ioral problems at a later age (Goodwin, Fergusson, & Horwood, 2004;
Ormel et al., 2015; Roza, Hofstra, van der Ende, & Verhulst, 2003).
Even though both the CBCL and the ASQ-SE-2 are screening instru-
ments rather than diagnostic evaluations, results on these screeners
clearly demonstrate higher risks for psychopathology for some chil-
dren with SCT, and the need for early monitoring and implementation
of intervention, especially in the domain of social–emotional
functioning.
In conclusion, our findings give some important implications for
clinical care. First of all, with the broad behavioral phenotype, it is
important to include behavioral screening in routine clinical care for
children with SCT, and to monitor the developmental trajectory. Diffi-
culties with social–emotional development seem most prominent, as
there is an increased risk already when children are 1-year-old, and
elevated scores were persistent across the full 1–5 year age range,
regardless of time of diagnosis, and across all three karyotypes. While
each child with SCT is different, our results suggest a pattern of affec-
tive and pervasive developmental problems emerging in the late-tod-
dler stage, and finally anxiety, attention deficits, and oppositional
defiant problems emerging during the preschool years. It is important
to monitor the behavioral development closely, with a focus on these
specific domains on specific ages, so interventions and preventive
support can be administered as early as possible, to optimize out-
comes. Routine screenings should be done from an early age onwards,
as behaviors can already be clinically relevant from a very young age,
and without early assessment, opportunities for early intervention
could be missed. In addition, it is important that parents who receive
the diagnosis are aware of the wide variability of outcomes, and
receive psycho-education on the possible behavioral problems, in par-
ticular affective problems, pervasive developmental problems, and
social–emotional development, as our results show that these difficul-
ties already arise at a very young age, and problems possibly could
intensify over time. Knowledge about these early neurobehavioral
risks should ideally fuel implementation of early interventions and
psycho-education, optimizing outcomes of children with SCT.
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